REQUEST A DEMO
Total
USD $0.00
Search more companies

Centro De Neurodesarrollo Y Aprendizaje Crecer Sas (Colombia)

Main Activities: Ambulatory Health Care Services
Secondary Activities: Educational Support Services | Other Ambulatory Health Care Services
Full name: Centro De Neurodesarrollo Y Aprendizaje Crecer Sas Profile Updated: March 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Spanish Download a sample report

Centro De Neurodesarrollo Y Aprendizaje Crecer Sas is based in Colombia, with the head office in La union. The company operates in the Ambulatory Health Care Services industry. It was established on September 04, 2020. From the latest financial highlights, Centro De Neurodesarrollo Y Aprendizaje Crecer Sas reported a net sales revenue increase of 420.54% in 2025. A growth of 92.19% was recorded in its total assets.

Headquarters
Barrio Carlos Lleras Carrera 1 No. 23 - 14
La union; Narino;

Contact Details: Purchase the Centro De Neurodesarrollo Y Aprendizaje Crecer Sas report to view the information.

Basic Information
Registered Capital:
Purchase the Centro De Neurodesarrollo Y Aprendizaje Crecer Sas report to view the information.
Financial Auditors:
Purchase the Centro De Neurodesarrollo Y Aprendizaje Crecer Sas report to view the information.
Incorporation Date:
September 04, 2020
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Centro De Neurodesarrollo Y Aprendizaje Crecer Sas report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
420.54%
Total Operating Revenue
420.54%
Operating Profit
166.83%
EBITDA
189.28%
Net Profit/Loss for the Period
N/A
Total Assets
92.19%
Total Equity
N/A
Operating Profit Margin
-10.25%
Net Profit Margin
N/A
Return on Equity (ROE)
-1.71%
Quick Ratio
-0.28%
Cash Ratio
-0.25%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?